Publication | Closed Access

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

ThrombosisPlatelet Aggregation InhibitorsPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletMedicineCardiovascular PharmacologyInitial ExperiencePharmacotherapyPlatelet AntagonistPharmacologyPhase IiCardiologyAcute Myocardial Infarction